 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Portola Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.

Current Price	$18.03
Prev Close	$17.99
Open	$18.00
Dividend Yield	0.00%
50-Day Moving Average	$16.20
Beta	1.37
Avg. Volume	1.85M
PE Ratio	N/A

52-Week High	$31.73
52-Week Low	$5.31
Market Capitalization	$1.42B
EPS	-$3.77
Price to Book	19.64
Revenue Per Employee	$296,225.49
Enterprise Value/EBITDA	-2.22

PTLA Portola Pharmaceuticals Inc.

About

Feed

Fundamentals

News